Health Care Management Papers

Document Type

Technical Report

Date of this Version

6-2015

Publication Source

International Journal of the Economics of Business

Volume

22

Issue

2

Start Page

245

Last Page

261

DOI

10.1080/13571516.2015.1045741

Abstract

The market-based US health care system relies on pharmacy benefit managers (PBMs) to control pharmaceutical costs, in contrast to most other countries that regulate drug prices and access. Optimal strucuturing and regulation of PBM contracts poses significant agency challenges for private and public payers. However, recent reporting requirements for PBMs may be counterproductive and reflect the interests of competitors rather than customers.

Copyright/Permission Statement

This is an Accepted Manuscript of an article published by Taylor & Francis in the International Journal of the Economics of Business on June 26, 2015, available online: http://dx.doi.org/10.1080/13571516.2015.1045741

Keywords

pharmaceuticals, pharmacy benefit management, insurance, transparency, regulation

Share

COinS
 

Date Posted: 26 June 2018

This document has been peer reviewed.